Windward Bio Group AG, a Swiss biopharmaceutical company, has filed a Form F-1 registration statement with the U.S. Securities and Exchange Commission to conduct an initial public offering of common shares. The company plans to list its shares on the Nasdaq Global Market under the symbol “WWB.” This offering will mark Windward Bio's first public sale of shares as no public market currently exists for its common stock.
Why it matters
Investors may monitor this registration filing as it signals Windward Bio's plans to go public, potentially providing new investment opportunities in the biopharmaceutical sector and insight into emerging growth companies from Switzerland.
Explore our permanent IPO company profile for the developing timeline.
This report is based on the official SEC F-1 filing dated 20261023. Offering terms may change; review the primary filing before making a decision.